CALGB 170601: A phase III double blind trial of duloxetine to treat painful chemotherapy-induced peripheral neuropathy (CIPN).
Ellen M. Lavoie Smith
No relevant relationships to disclose
Herbert Pang
No relevant relationships to disclose
Constance Cirrincione
No relevant relationships to disclose
Stewart Barry Fleishman
No relevant relationships to disclose
Electra D. Paskett
Research Funding - Merck
Camilo E. Fadul
No relevant relationships to disclose
Chetaye Knox
No relevant relationships to disclose
Charles L. Shapiro
No relevant relationships to disclose
Paul Gilman
No relevant relationships to disclose